The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,3'-(2-oxopropane-1,3-diyl)bis(3-hydroxyindolin-2-one) ID: ALA4753538
Cas Number: 76325-81-0
PubChem CID: 299561
Max Phase: Preclinical
Molecular Formula: C19H16N2O5
Molecular Weight: 352.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CC1(O)C(=O)Nc2ccccc21)CC1(O)C(=O)Nc2ccccc21
Standard InChI: InChI=1S/C19H16N2O5/c22-11(9-18(25)12-5-1-3-7-14(12)20-16(18)23)10-19(26)13-6-2-4-8-15(13)21-17(19)24/h1-8,25-26H,9-10H2,(H,20,23)(H,21,24)
Standard InChI Key: ROCVBZTWTGXHKR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.3253 -3.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0330 -3.2110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7408 -3.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0330 -2.3938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4485 -3.2110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6176 -3.2110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3314 -2.2275 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5321 -2.3975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5320 -2.3962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7326 -2.2263 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7400 -2.9353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1939 -3.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4439 -4.3115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2396 -4.4818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7849 -3.8733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5320 -3.1030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8709 -3.5412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3271 -2.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5306 -3.1005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2768 -3.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8256 -4.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6201 -4.3128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9242 -1.8515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1393 -1.8494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6113 -4.0282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4426 -4.0240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
1 6 1 0
5 12 1 0
11 7 1 0
7 8 1 0
8 5 1 0
6 9 1 0
9 10 1 0
10 18 1 0
17 6 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
8 23 2 0
9 24 2 0
6 25 1 0
5 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.35Molecular Weight (Monoisotopic): 352.1059AlogP: 1.02#Rotatable Bonds: 4Polar Surface Area: 115.73Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.24CX Basic pKa: ┄CX LogP: 0.85CX LogD: 0.85Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: 0.37
References 1. Liu Q,Miao Y,Wang X,Lv G,Peng Y,Li K,Li M,Qiu L,Lin J. (2020) Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors., 186 [PMID:31785819 ] [10.1016/j.ejmech.2019.111905 ]